Development and Evaluation of an Optimal Human Single-Chain Variable Fragment-Derived BCMA-Targeted CAR T Cell Vector

類似資料

• BCMA-targeted CAR T-cell therapy plus radiation therapy for the treatment of refractory myeloma reveals potential synergy
  著者:: Smith, Eric L., 等
  出版事項: (2019)
• Defining an Optimal Dual-Targeted CAR T-cell Therapy Approach Simultaneously Targeting BCMA and GPRC5D to Prevent BCMA Escape–Driven Relapse in Multiple Myeloma
  著者:: Fernández de Larrea, Carlos, 等
  出版事項: (2020)
• GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells
  著者:: Smith, Eric L., 等
  出版事項: (2019)
• How do CARs work?: Early insights from recent clinical studies targeting CD19
  著者:: Davila, Marco L., 等
  出版事項: (2012)
• Armored CAR T cells enhance antitumor efficacy and overcome the tumor microenvironment
  著者:: Yeku, Oladapo O., 等
  出版事項: (2017)